并购重组复星医药:子公司受让复宏汉霖2103.43万股非上市股份复星医药公告,基于对复宏汉霖发展的信心及价值的认可,4月11日至4月17日期间,控股子公司复星医药产业与上海善梧、无锡通善、舟山果运及Henlink分别达成转让协议,拟以港币24.60元/股的价格受让该等卖方持有的合计2103.43万股复宏汉霖非上市股份,转让价款共计5.17亿元港元(或等值人民币)。本次增持完成后,本集团持有复宏汉霖...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.